Page last updated: 2024-08-17

amifampridine and ALS - Amyotrophic Lateral Sclerosis

amifampridine has been researched along with ALS - Amyotrophic Lateral Sclerosis in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aisen, ML; Blass, J; Blau, A; Edelstein, L; Gibson, G; Hatch, J; Kutt, H; Sevilla, D	1
Aisen, ML; Blass, J; Edelstein, L; Sevilla, D	1

Trials

1 trial(s) available for amifampridine and ALS - Amyotrophic Lateral Sclerosis

Article	Year
A double-blind placebo-controlled study of 3,4-diaminopyridine in amytrophic lateral sclerosis patients on a rehabilitation unit. Journal of the neurological sciences, 1996, Volume: 138, Issue:1-2 Topics: 4-Aminopyridine; Administration, Oral; Aged; Amifampridine; Amyotrophic Lateral Sclerosis; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Middle Aged; Muscle Weakness; Neural Conduction; Potassium Channel Blockers; Psychomotor Performance	1996

Article

Year

A double-blind placebo-controlled study of 3,4-diaminopyridine in amytrophic lateral sclerosis patients on a rehabilitation unit.

Journal of the neurological sciences, 1996, Volume: 138, Issue:1-2

Topics: 4-Aminopyridine; Administration, Oral; Aged; Amifampridine; Amyotrophic Lateral Sclerosis; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Middle Aged; Muscle Weakness; Neural Conduction; Potassium Channel Blockers; Psychomotor Performance

1996

Other Studies

1 other study(ies) available for amifampridine and ALS - Amyotrophic Lateral Sclerosis

Article	Year
3,4-diaminopyridine as a treatment for amyotrophic lateral sclerosis. Journal of the neurological sciences, 1995, Volume: 129, Issue:1 Topics: 4-Aminopyridine; Affect; Aged; Amifampridine; Amyotrophic Lateral Sclerosis; Cognition; Female; Humans; Male; Middle Aged; Movement; Neural Conduction	1995